Iaso Thessalia General Clinic Private Obstetrics S.A.
- Address
- lock Available on a paid plan
Eye Diseases and Diagnostic Techniques
At Iaso Thessalia General Clinic Private Obstetrics S.A., research in ophthalmology focuses on glaucoma, ocular hypertension, and related eye conditions. These studies are designed to compare established and newer eye drop treatments, while also supporting better approaches to diagnosis and pupil dilation for clinical use.
- Testing new generic eye drop combinations for open-angle glaucoma and ocular hypertension
- Evaluating treatment effectiveness by measuring changes in intraocular pressure
- Studying mydriatic eye drops to support pre-operative and diagnostic eye care
This area of research aims to improve everyday eye care by confirming whether alternative formulations can perform as well as reference treatments and help protect vision.
Cardiovascular Disease and Heart Failure
The site also supports research in cardiovascular diseases, with a focus on heart failure with preserved ejection fraction and heart failure with mildly reduced ejection fraction in people living with obesity. These trials are looking at whether a new therapy can lower the risk of serious heart-related events when added to standard care.
- Studying heart failure outcomes in patients with obesity
- Assessing whether treatment can reduce hospitalisation and urgent care visits
- Comparing a new therapy with placebo alongside standard treatment
This work is aimed at improving long-term management of complex heart failure, especially where weight-related health issues may add to the burden of disease.
Autoimmune and Inflammatory Disease Research
Clinical research at the clinic also includes systemic lupus erythematosus, a chronic autoimmune disease that can affect multiple organs. The trial activity in this area is focused on evaluating a new treatment option to better control disease activity when used with standard care.
- Investigating treatment effectiveness in systemic lupus erythematosus
- Measuring changes in overall disease activity
- Exploring whether a new therapy may improve care for patients with active disease
This research reflects an effort to expand options for people living with a complex autoimmune condition that often requires careful, ongoing management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1OmniVision GmbH1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1OmniVision GmbH2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 173 other sites in Greece
Therapeutic Area Benchmark — Greece
Select a therapeutic area to compare against other sites in Greece.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Greece
Market Share
Country: Greece
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Iaso Thessalia General Clinic Private Obstetrics S.A.
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Non-Inferiority Study Comparing Brimonidine Tartrate and Timolol Fixed-Dose Combination Eye Drops to an Active Comparator in Patients with Open-Angle Glaucoma or Ocular Hypertension | OmniVision GmbH | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 13 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Brimonidine Tartrate | 2 | Unknown | 2024-05-31 | 2024-05-31 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
